SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Gravitas Collective Discloses 19.9% Stake in Hepion Pharmaceuticals

Gravitas Collective Corp. reported a 19.9% stake in Hepion Pharmaceuticals, receiving 25 million shares in exchange for its membership interests in Gravitas Life Sciences. The exchange took place on October 6, 2026.

HEPA

Related stories